620.48 USD
▲+25.07+4.21%
盘后 622.00 +0.24%
2026-09-15
市值
$17.32B
市盈率
36.38
EPS
17.06
股息率
—
52 周区间
373.00 – 677.90
成交量
303.85K
Beta
1.15
目标价
581.83
52W 低 373.0052W 高 677.90
价格走势
公司简介
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data man...